Miguel García-Guzman, Ph.D.
Aspyrian Therapeutics
Dr. García-Guzman is the Chief Scientific Officer of Aspyrian Therapeutics, a Biotechnology company developing oncology drugs for the treatment of solid tumors. Before, he was an Associate Director at Vertex Pharmaceuticals San Diego Laboratories, where he led preclinical programs in the areas of GPCRs and pain drug discovery. Prior to joining Vertex, Dr. García-Guzman worked at Aurora Biosciences, a biotech company later acquired by Vertex, The Burnham Institute for Medical Research, and the Max-Planck Institute of Göttingen, where he characterized novel ligand-gated ion channels.
© 2020 RetroVirox, Inc. All rights reserved